In the last trading session, 1.36 million ARS Pharmaceuticals Inc (NASDAQ:SPRY) shares changed hands as the company’s beta touched 0.79. With the company’s per share price at $14.26 changed hands at $0.66 or 4.85% during last session, the market valuation stood at $1.40B. SPRY’s last price was a discount, traded about -29.8% off its 52-week high of $18.51. The share price had its 52-week low at $7.55, which suggests the last value was 47.05% up since then.
Analysts gave the ARS Pharmaceuticals Inc (SPRY) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 4 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended SPRY as a Hold, 4 felt it is a Buy and 0 rated the stock as Underweight.
ARS Pharmaceuticals Inc (NASDAQ:SPRY) trade information
Instantly SPRY was in green as seen at the end of in last trading. With action 7.30%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 35.17%, with the 5-day performance at 7.30% in the green. However, in the 30-day time frame, ARS Pharmaceuticals Inc (NASDAQ:SPRY) is -4.17% down.
The consensus price target for the stock as assigned by Wall Street analysts is 22, meaning bulls need an upside of 35.18% from its current market value. According to analyst projections, SPRY’s forecast low is 18 with 30 as the target high. To hit the forecast high, the stock’s price needs a -110.38% plunge from its current level, while the stock would need to soar -26.23% for it to hit the projected low.
ARS Pharmaceuticals Inc (SPRY) estimates and forecasts
The 2025 estimates are for ARS Pharmaceuticals Inc earnings to decrease by -1939.58%, but the outlook for the next 5-year period is at 55.24% per year.
ARS Pharmaceuticals Inc (NASDAQ:SPRY)’s Major holders
RA CAPITAL MANAGEMENT, L.P. holds the second largest percentage of outstanding shares, with 11.2168% or 10.86 million shares worth $92.43 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF. With 1.99 shares estimated at $28.39 million under it, the former controlled 2.03% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 1.33% of the shares, roughly 1.3 shares worth around $18.6 million.
